Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Govt seeks public opinion on draft consumer policy
The government has formulated a draft national consumer policy with an aim to ensure that goods, services and technology are available to the consumers at reasonable prices and good quality.

Ex-Axis Bank chief joins Advent Int'l as operating partner
Advent International, the global private equity firm, today announced that P Jayendra Nayak has joined Advent’s Operating Partner Programme to advise on Indian investment opportunities, especially those in the financial services sector, and the development of Advent’s business in India.

News of the day

Technical textile consumptions to cross Rs 2,200 cr by 2013
The consumption of technical textiles, used in the healthcare industry, in India is growing and the industry body Ficci wants the government to provide capital subsidy to the domestic companies to meet the demand.
Online Business

Govt stays suspension on Natco's Albupax licence

Government of India has stayed suspension of Natco Pharma"s Albupax manufacturing (product) licence. Albupax is a nanotechnology based drug and is the first generic version of the international brand Abraxane of Abraxis Bioscience Inc, USA. Albupax consists of Paclitaxel in an albumin-bound nanoparticle form and is used to treat breast cancer. - Natco Pharma, Apollo Hospitals, Sundram Fasteners & Emami Q2 result - Natco to release 1 mn doses of H1N1 drug - Natco to release 1 mn Natflu doses by Oct end - Natco Pharma launches anti-swine flu drug, Natflu - Natco stops production of breast cancer drug on liver concerns - Natco Pharma FY09 net rises 8.5% at Rs 44 cr Drugs Controller General of India (DCGI) had suspended Natco Pharma"s manufacturing license allegedly for not passing the test measuring endotoxin levels. Later, Natco Pharma appealed under the Drugs and Cosmetics Rules against the suspension order. Natco"s plea said an appropriate test method needs to be employed to evaluate nanotechnology based protein-bound formulations as the testing method used for such formulations are highly complex and variable. Natco would soon announce the future plans.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009